Table 2: Combination photodynamic therapy with ranibizumab or bevacizumab for treatment of wet age-related macular degeneration: Treatment outcome in Group A
| Close | |
|
|
|
|
Table 2: Combination photodynamic therapy with ranibizumab or bevacizumab for treatment of wet age-related macular degeneration: Treatment outcome in Group A
|
|